Approximately 12,500 nephrologists and other kidney professionals from around the world, recently came together for Kidney Week - the world’s largest scientific meeting in the field of nephrology - hosted by the American Society of Nephrology (ASN). 

Held between 3 - 6 November, in Philadelphia, PA, the event  included a series of scientific sessions and poster presentations, showcasing groundbreaking advancements in basic to translational research, covering Chronic Kidney Disease (CKD), dialysis and renal transplantation. It also provided an invaluable opportunity for fostering fruitful connections with peers from different companies and scientific institutions.

Diaverum’s Medical Team was an active participant during the event, having presented two posters. The first, presented by Dr Mathias Haarhaus, Corporate Head of Science & Research and Country Medical Director for Sweden, was titled “Better quality of life in postdilution compared to predilution haemofiltration in a European cohort of hemodialysis patients”. Mathias said: “Our study showed that patients receiving postdilution haemofiltration (HDF), have better mental and physical Quality of Life, and improved symptoms.  While the optimal dialysis strategy is always decided based on the characteristics and needs of the individual patient, the results of this study show positive patient reported outcomes of postdilution HDF, a factor which has not been well-studied to date”. 

The second, presented by Dr Shaira Martínez, Country Medical Director, and Teresa Martínez, Business Development Director, both of Diaverum Spain, was titled “Assessing the value of an integrated multidisciplinary patient centric programme for patients in haemodialysis”. Commenting on the presentation Shaira said:Chronic Kidney Disease is a major public health concern, due to notable morbidity, mortality and associated costs. Our study showed that our Patient Care Coordination Programme, which provides comprehensive and personalised care to haemodialysis patients, is more effective in addressing the challenges of CKD and optimising healthcare resource allocation, compared to standard of care”.

Dr Fernando Macário, Chief Medical Officer, who led the group of delegates, in the event, commented: “I am sincerely grateful for the opportunity to participate in this prestigious event for another year, and extremely proud of our team’s compelling presentations. Once again, we succeeded in showcasing our ongoing commitment to offering life-enhancing renal care, through a multidisciplinary, integrated approach.

News

Growth

Diaverum Morocco expands its network of clinics

Growth

Diaverum Kazakhstan reaches 3,000 patients

Growth

Diaverum UK wins major tender in South West England